公募基金方面，本期较上一季未再披露的公募基金共计69个，主要包括中信建投轮换混合A、鹏华碳中 和主题混合A、中信建投甄选混合A、博时科创板三年定开混合、恒越成长精选混合A等。 2025年10月25日，创耀科技(688259.SH)发布2025年第三季报。截至2025年10月24日，共有7个机构投资 者披露持有创耀科技A股股份，合计持股量达5793.87万股，占创耀科技总股本的51.87%。其中，机构 投资者包括重庆创睿盈企业管理有限公司、宁波保税区凯风创业投资管理有限公司-湖州凯风厚泽股权 投资合伙企业(有限合伙)、中新苏州工业园区创业投资有限公司、长江成长资本投资有限公司、寿宁投 资管理(上海)有限公司-寿宁点金12号私募证券投资基金、舟山半夏投资合伙企业(有限合伙)、新余高新 区美圣企业管理咨询合伙企业(有限合伙)，机构投资者合计持股比例达51.87%。相较于上一季度，机构 持股比例合计下跌了4.18个百分点。 ...

2025年10月25日，华正新材(603186.SH)发布2025年第三季报。截至2025年10月24日，共有7个机构投资 者披露持有华正新材A股股份，合计持股量达6703.15万股，占华正新材总股本的47.20%。其中，机构 投资者包括华立集团股份有限公司、全国社保基金六零一组合、交通银行股份有限公司-易方达科讯混 合型证券投资基金、交通银行股份有限公司-易方达科融混合型证券投资基金、中国建设银行股份有限 公司-易方达创新驱动灵活配置混合型证券投资基金、易方达基金管理有限公司-社保基金17042组合、 中国银行股份有限公司-易方达成长动力混合型证券投资基金，机构投资者合计持股比例达47.20%。相 较于上一季度，机构持股比例合计上涨了4.66个百分点。 对于社保基金，本期新披露持有华正新材的社保基金共计2个，包括全国社保基金六零一组合、易方达 基金管理有限公司-社保基金17042组合。 以上内容与数据，与有连云立场无关，不构成投资建议。据此操作，风险自担。 公募基金方面，本期较上一季度新披露的公募基金共计4个，包括易方达科讯混合、易方达科融混合、 易方达创新驱动混合、易方达成长动力混合A。本期较上一季未再披 ...

Core Viewpoint - Enhua Pharmaceutical (002262.SZ) reported its semi-annual results for 2025, highlighting significant institutional investment and changes in public fund holdings [1][2]. Institutional Holdings - As of July 29, 2025, 22 institutional investors disclosed holdings in Enhua Pharmaceutical, totaling 374 million shares, which represents 36.83% of the company's total equity [1]. - The top ten institutional investors collectively hold 36.56% of the shares, with a slight increase of 0.09 percentage points compared to the previous quarter [1]. Public Fund Holdings - Three public funds reduced their holdings compared to the previous quarter, with a total decrease of 0.42% [2]. - Twelve new public funds disclosed holdings in Enhua Pharmaceutical, including notable names such as Southern CSI 500 ETF and Dachen Active Growth Mixed A [2]. - Fifteen public funds that previously held shares did not disclose their holdings this quarter, including several healthcare-focused funds [2]. Social Security Fund - One new social security fund, the National Social Security Fund 406 Combination, disclosed its holdings in Enhua Pharmaceutical during this period [2]. Insurance Capital - One insurance company, China Life Insurance Co., Ltd. - Traditional - Ordinary Insurance Product - 005L-CT001, increased its holdings by 0.2% compared to the previous period [2]. Foreign Investment - One foreign institution, Hong Kong Central Clearing Limited, did not disclose its holdings this quarter, indicating a potential shift in foreign investment interest [3].

Group 1 - The core viewpoint of the news is that Meixinsheng (688458.SH) reported its Q1 2025 results, highlighting significant institutional investor interest with 22 institutions holding a total of 47.68 million shares, representing 42.75% of the total share capital [1] - The top ten institutional investors collectively hold 41.74% of the shares, which is a decrease of 2.57 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, five funds increased their holdings, accounting for 1.11% of the total, while seven funds reduced their holdings, indicating a slight decline [2] - One new public fund was disclosed during this period, while 71 funds were not disclosed again, indicating a shift in investor interest [2]